An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients

Active, not recruitingOBSERVATIONAL
Enrollment

202

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Asthma
Trial Locations (30)

Unknown

Research Site, Hohhot

Research Site, Beijing

Research Site, Changsha

Research Site, Chengdu

Research Site, Foshan

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Hangzhou

Research Site, Hefei

Research Site, Jinan

Research Site, Kunming

Research Site, Nanchang

Research Site, Nanjing

Research Site, Ningbo

Research Site, Qingdao

Research Site, Quanzhou

Research Site, Shanghai

Research Site, Shenyang

Research Site, Shenzhen

Research Site, Shijiazhuang

Research Site, Suining

Research Site, Taiyuan

Research Site, Tianjin

Research Site, Ürümqi

Research Site, Wenzhou

Research Site, Wuhan

Research Site, Wuxi

Research Site, Xi'an

Research Site, Zhengzhou

Research Site, Zhuhai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY